Swedish biotech Medivir and Cancer Research Technology (CRT) are teaming up to develop a new class of drugs that have shown promise in various cancer types. Medivir and CRT, Cancer Research UK’s commercialization and development arm, said that they have partnered to develop a new class of drugs targeting ADAM8, …